Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder: subgroup analyses

被引：0
|
作者：
Vieta, E. [1 ]
Loft, H. [2 ]
Florea, I. [2 ]
机构：
[1] Univ Barcelona, Clin Inst Neurosci Hosp Clin, Bipolar Disorders Program, Barcelona, Spain
[2] H Lundbeck & Co AS, Brintellix Clin Sci, Copenhagen, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.h.008
引用
收藏
页码：S458 / S458
页数：1
相关论文
共 50 条
  • [31] Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
    Christensen, Michael Cronquist
    Schmidt, Simon
    Grande, Iria
    JOURNAL OF PSYCHOPHARMACOLOGY, 2022, 36 (05) : 566 - 577
  • [32] Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
    Almeida, Susana S.
    Christensen, Michael Cronquist
    Simonsen, Kenneth
    Adair, Michael
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (03) : 279 - 288
  • [33] Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder
    Baethge, C
    Gruschka, P
    Smolka, MN
    Berghöfer, A
    Bschor, T
    Müller-Oerlinghausen, B
    Bauer, M
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (05): : 355 - 361
  • [34] Escitalopram and paroxetine in the short and long-term treatment of major depressive disorder (MDD)
    Baldwin, D
    Hindmarch, I
    Huusom, AKT
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S168 - S169
  • [35] Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder
    Baldessarini, Ross J.
    Lau, Wai Keat
    Sim, Jordan
    Sum, Min Yi
    Sim, Kang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (03):
  • [36] Guide for evaluation and improvement of long-term treatment compliance of Major Depressive Disorder
    Montejo, A. L.
    Menchon, J. M.
    Carrasco, J. L.
    Franco, M.
    Martin Carrasco, M.
    Morinigo, A.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2010, 38 : 1 - 27
  • [37] Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
    Alvarez, Enric
    Perez, Victor
    Artigas, Francesc
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1297 - 1307
  • [38] Efficacy of vortioxetine in the treatment of cognitive symptoms of major depressive disorder
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Santamaria, O.
    Gotor Sanchez-Luengo, F.
    Navarro, R.
    EUROPEAN PSYCHIATRY, 2018, 48 : S206 - S206
  • [39] A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder
    Bose, Rohini
    Hamdani, Syed Usman
    Minhas, Fareed Aslam
    Herr, Keira Joann
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (05) : 661 - 671
  • [40] Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder
    Cuomo, Alessandro
    Barilla, Giovanni
    Cattolico, Matteo
    Pardossi, Simone
    Mariantoni, Elisa
    Koukouna, Despoina
    Carmellini, Pietro
    Fagiolini, Andrea
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (05) : 465 - 476
12345